CDC TB

CDC TB

Share

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022–2024 01/27/2026

Even with newer, shorter, and better-tolerated treatments, drug-resistant tuberculosis remains rare in the U.S.—but challenging when it occurs. 🧬💊

A new article from CDC and partners highlights what clinicians may encounter in these uncommon cases and why continued vigilance matters:

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022–2024 AbstractBackground. Bedaquiline, pretomanid, and linezolid with or without moxifloxacin (BPaL/M) are recommended oral 6-month treatment regimens for multid

01/02/2026

Do you know the symptoms of tuberculosis disease? The symptoms depend on where in the body the tuberculosis germs are growing. Learn more: https://bit.ly/4cMOYqU

12/17/2025

If you have been around someone who has active tuberculosis disease, contact your health care provider about getting tested, even if you do not feel sick. Read more: https://bit.ly/4c6N03Q

12/09/2025

Drug-resistant tuberculosis disease is complicated. Taking medication as prescribed helps prevent drug-resistance. Learn more: https://buff.ly/5zlHqrg

11/25/2025

Health care workers: are you looking for a refresher on your TB knowledge? Take CDC’s TB 101 for Health Care Workers Training: https://buff.ly/d3nFqgk

11/20/2025

Learn how engaging with other TB patients and survivors can help people currently in treatment feel supported, less isolated, and empowered to complete treatment: https://buff.ly/xqRfdCo

Want your organization to be the top-listed Government Service in Atlanta?
Click here to claim your Sponsored Listing.

Address


Atlanta, GA